Saturday, May 10, 2008
Portfolio News
Intercytex plc: funding award from US GovernmentAFIRM will use regenerative medicine to develop new treatments for battlefield injuries
Published: 2008-04-18 08:04:03
Recommended Acquisition of CENES PHARMACEUTICALS PLC by PAION AG
Published: 2008-04-10 08:48:37
CeNeS Pharmaceuticals plc proposed acquisition by PAION AG
Published: 2008-04-10 08:34:36
York Pharma: date of interim results and trading update
Published: 2008-04-09 08:25:33
Intercytex: Preliminary results for the year ended 31 December 2007
Published: 2008-03-18 07:41:10
CeNeS Pharmaceuticals plc - Potential Offer
Published: 2008-02-05 14:14:28
Intercytex - Year-end clinical trial update
Published: 2007-12-18 08:10:36
Aitua Ltd Portfolio Company Establishes Worldwide Distributor Network
Lightning-Link™ company Innova completes agreement with Japanese distributor
Published: 2007-12-13 11:24:54
CeNeS - Update on M6G
Published: 2007-12-06 08:41:17
York Pharma Preliminary Results for the Year Ended 30 Sep 2007
Published: 2007-11-23 08:32:12
CellCentric and Cancer Research Technology Collaboration
Published: 2007-11-14 09:43:58
York Pharma plc Research Update
New Abasol(TM) formulation for onychomycosis can effectively and rapidly penetrate the nail barrier
Published: 2007-10-30 11:31:55
York Pharma plc £17.5m Acquisition of Derms Development
Published: 2007-10-09 08:39:14
CellCentric receives funding from Takeda Research Investment, Inc.
Existing shareholders including Morningside and NESTA contribute to Series A fund alongside the endorsement from a corporate pharmaceutical investor.
Published: 2007-10-02 08:40:46
Recommended Cash Offer for COZART PLC by CONCATENO PLC
Published: 2007-10-01 12:58:17
Intercytex Group plc Interim results for the six months ended 30 June 07
Published: 2007-09-25 10:52:47
CeNeS Interim Results for the six months ended 30 June 2007
Published: 2007-09-13 13:59:16
CeNeS: Start of Recruitment for Phase II trial of CNS 5161 in cancer pain
Published: 2007-09-10 11:45:04
Cozart plc - Recommended Cash Offer by Concateno plc
Published: 2007-09-05 08:02:44
Cozart plc - Preliminary Results
Cozart plc increases revenue by 52% and trebles operating profit
Published: 2007-09-05 07:43:57
Cozart plc - Rule 2.4 announcement
Published: 2007-09-04 09:26:51
CeNeS Pharmaceuticals plc - AGM and EGM
Published: 2007-08-22 10:46:38
CeNeS Licenses New Intravenous Anaesthetic to Ono in Japan
Published: 2007-08-06 10:28:56
Cozart plc - Home Office Expands Drugs Intervention Programme
Published: 2007-07-30 07:42:36
CeNeS: Proposed placing to raise £6.1m and consolidation of share capital
Published: 2007-07-27 11:06:06
Intercytex announces introduction of Vavelta at FACE
Published: 2007-07-02 07:50:14
Cozart Signs Commercialisation Agreement with Philips Electronics
Cozart to market Cozart-Philips drug testing product worldwide Philips increases equity stake in Cozart to 9%
Published: 2007-06-28 07:48:03
Intercytex announcement - world first in skin repair
Published: 2007-06-26 08:55:51
CeNeS Pharmaceuticals plc Pipeline Update – CNS 7056
Published: 2007-06-20 08:44:54
CellCentric signs IP agreement with Massachusetts General Hospital
Published: 2007-06-15 12:12:15
CeNeS announces further statistical analysis of recent Phase III trial
Further statistical analysis of the recent Phase III trial on Lead Product M6G shows additional benefits
Published: 2007-06-08 08:21:28
Cozart appointed into 4-year Framework Agreement with UK Home Office
Published: 2007-06-06 08:12:08
Cozart plc awarded contract with Emirates Airlines
Published: 2007-05-09 08:03:16
Intercytex Group plc - Proposed Placing
Published: 2007-05-03 08:06:51
Cozart: Scottish Executive awards contract for Oral Fluid Drug testing
Published: 2007-04-10 09:16:12
De Novo Announces New Partnering Opportunity in Diabetes
Published: 2007-04-09 12:13:17
York Pharma plc Pre-close Trading Update
Strong progress on product pipeline
Published: 2007-03-28 13:39:45
CeNeS: Preliminary results for the year ended 31 December 2006
Product profile of lead drug candidate (M6G) confirmed in large Phase III study International partnering process to commercialise M6G underway
Published: 2007-03-28 12:04:17
CeNeS Appoints Rodman & Renshaw to assist in partnering of M6G
Published: 2007-03-28 12:02:45
CeNeS: IND For Lead Product M6G Filed
Published: 2007-03-28 12:01:09
Intercytex Preliminary results for the year ended 31 December 2006
Published: 2007-03-23 14:34:21
Acquisition of DanioLabs
Associated Link - Acquisition strengthens Avlar BioVentures in VC market - press release 2 October 2006
Published: 2007-03-22 14:42:48
Takeda to Acquire Paradigm Therapeutics
Published: 2007-03-12 09:55:54
MDY Healthcare plc participates in fundraising of Cozart plc
Fundraising to finance acquisition of Nemesis Scientific Limited
Published: 2007-03-02 10:25:30
Cozart plc Acquisition of Nemesis Scientific Limited
Expansion of presence in the workplace drug testing market
Published: 2007-03-02 10:22:02
Amura Holdings Ltd assignment of rights to ProtoDiscovery™ platform
Published: 2007-02-21 15:49:32
CeNeS: Successful Phase III results announced on Lead Product M6G
Phase III trial in Europe demonstrates M6G\'s benefit compared to morphine in the treatment of post-operative pain.
Published: 2007-02-20 08:04:29
CeNeS announces update on its portfolio of carried interests
Published: 2007-02-20 07:58:29
Intercytex: Skin graft substitute (ICX-SKN) commences Phase I
Published: 2007-02-19 13:07:49
Cozart doubles turnover compared to H1 2005/6
Considerable progress made on joint development, with Philips Electronics, of biosensor saliva drugs of abuse system
Published: 2007-01-25 14:28:42
CellCentric expands its epigenetic discovery network
Published: 2007-01-24 11:57:30
CeNeS Pharmaceuticals plc: Placing to raise £4.82m
Published: 2006-12-04 10:16:07
Amura - orally active cathepsin K inhibitors with anti-osteoclast activity
Published: 2006-11-23 09:57:09
CeNeS Pharmaceuticals plc Positive Clinical Study Published on M6G
Published: 2006-10-19 09:28:49
Intercytex awarded £1.85m grant from the DTI
Intercytex awarded £1.85m grant from the DTI to automate production of innovative hair regeneration therapy
Published: 2006-10-06 08:20:15
Babraham BioConcepts announces key appointments
Published: 2006-10-06 08:03:34
Acquisition strengthens Avlar BioVentures in VC market
Published: 2006-10-02 15:07:49
CeNeS plc Interim Results for the six months
Published: 2006-09-28 09:39:50
CeNeS plc Update on Lead Product M6G
Published: 2006-09-28 09:33:00
Intercytex Group plc - Interim results for six months ended 30 June 06
Intercytex Group plc (LSE: ICX) announces its interim results for the six months ended 30 June 2006.
Published: 2006-09-21 11:11:37
Cozart plc Directors Share Purchase
Published: 2006-09-20 11:36:22
Cozart plc - extension to Home Office contract
Home Office extends contract for a further 12 months - extended until 31 March 2008
Published: 2006-09-19 15:01:24
Intercytex announces Phase II trial of ICX-PRO
Chronic woundcare product (ICX-PRO) commences Phase II trial in diabetic foot ulcers
Published: 2006-09-05 14:56:11
Launch of Babraham BioConcepts Ltd
£1 million investment by Avlar BioVentures
Published: 2006-09-05 11:13:30
Cozart plc Preliminary Results
Cozart reaches profitability as revenue doubles
Published: 2006-08-31 13:04:14
Amura announces notification of grant for the European phase of WO02057270
Published: 2006-08-21 10:04:56
Cozart achieves UKAS accreditation
Published: 2006-08-01 10:55:44
Cozart plc acquires HL Scandinavia AB
Cozart plc expands its presence in Swedish drug testing market with the acquisition of HL Scandinavia AB
Published: 2006-07-31 08:14:37
York Pharma plc Research Update (Sabarep(tm) - YP001)
Published: 2006-07-31 08:00:15
Intercytex: Facial rejuvenation product Phase I Study completed
Published: 2006-07-20 10:10:49
CellCentric raises £1.2m of venture capital
Morningside joins first round funders
Published: 2006-07-18 12:25:25
CeNeS Pharmaceuticals Extract from AGM Statement
Published: 2006-07-13 11:48:42
CeNeS acquires transdermal patch formulation IP
CeNeS acquires transdermal patch formulation IP relating to its neuropathic pain compound CNS 5161 from ALZA Corporation
Published: 2006-07-13 11:46:02
CeNeS and ERGOMED announce Revenue Sharing and Co-Development Agreement
CeNeS and ERGOMED announce Revenue Sharing and Co-Development Agreement for CNS 5161 and commencement of two Phase II studies in diabetic neuropathic pain and cancer pain
Published: 2006-07-13 11:43:52
Intercytex expands Executive Management Team
Published: 2006-07-10 14:32:59
Paradigm raises £7 million in fourth funding round
Published: 2006-07-07 14:45:49
Cozart launches Spinlab DoA: automated saliva and urine drug testing range
Published: 2006-07-07 14:35:57
Cozart secures US Patent for Lead Products
Published: 2006-07-07 14:23:50
Cozart plc - Analyst visit to Spinreact SA
Published: 2006-07-06 14:14:46
Drug discovery and commercial experience boost CellCentric team
CellCentric, the biotechnology company unlocking epigenetic control mechanisms, has made three senior appointments to strengthen its board and develop IP emerging from its research network.
Published: 2006-06-28 10:36:05
Cozart launches leading saliva-based hand-held drug detection system
Cozart launches the world's leading saliva-based hand-held drug detection system
Published: 2006-05-17 08:08:43
Cozart wins new £2.0 million DNA sampling kit supply contract
Cozart wins new £2.0 million DNA sampling kit supply contract
Published: 2006-05-11 09:04:09
CellCentric receives £1.15m DTI award
CellCentric, a leading company in epigenetics, today announced that it has been awarded £1.15m from the Department of Trade and Industry’s (DTI) Technology Programme
Published: 2006-05-04 09:20:46
CeNeS announces preliminary results for the year ended 31 December 2005
Published: 2006-04-10 13:00:18
CellCentric attracts Dr Tim Fell as COO
CellCentric attracts Dr Tim Fell as COO
Published: 2006-04-05 11:12:42
Cozart plc - City of London Police begins drug testing
City of London Police begins drug testing on arrest with Cozart RapiScan drug testing system
Published: 2006-03-31 15:19:24
Cozart plc - 127 police custody sites to start drug testing
127 police custody sites to start drug testing of arrestees using Cozart(R) RapiScan from today
Published: 2006-03-31 15:11:04
York Pharma - New patent filing covering a novel class of drugs
York Pharma plc - New patent filing covering a novel class of drugs and their use in the treatment of a wide range of skin diseases and certain cancers
Published: 2006-03-31 15:05:04
York Pharma - New clinical research findings
York Pharma Hitchin, UK, 20 March 2006 - New clinical research findings support York Pharma’s novel approach in the treatment of eczema and related disorders of the skin
Published: 2006-03-31 14:41:06
Intercytex first day of dealings on AIM
Published: 2006-02-01 09:16:17
Intercytex announces AIM flotation and placing
Intercytex announces AIM flotation and placing 27th January 2006
Published: 2006-01-27 09:02:34
Cozart announces 54% growth in turnover to £3.8 million
Interim Results Cozart announces 54% growth in turnover to £3.8 million. Monthly turnover in October, November and December each in excess of £1 million.
Published: 2006-01-25 09:03:35
Cozart to develop next generation of saliva drugs of abuse tests
Cozart to develop next generation of saliva drugs of abuse tests in collaboration with Philips. Philips to take 4.8% equity stake in Cozart.
Published: 2006-01-25 08:46:21
ImmunoBiology Ltd announces completion of €8m series C funding round
ImmunoBiology Ltd. is pleased to announce the closing of its Series C funding round.
Published: 2006-01-23 12:05:37
Cozart Subsidiary Wins Workplace Drug Testing Contract to Test Swedish Post
Cozart plc (AIM: CZT), the medical diagnostics company, announces that Medib Scandinavien AB, Cozart’s Swedish subsidiary, has won a workplace drug testing contract to test Swedish post office drivers, at random, for drugs and alcohol.
Published: 2006-01-11 10:50:01
CellCentric - New cancer treatment
New type of drug offers chance to 'switch off' cancer treatment
Published: 2006-01-03 12:32:38
York Pharma - appointments
York Pharma appoints new Non-Executive Director
Published: 2005-12-01 16:31:19
Cozart PLC - Re: Arrestees Programme
Home Office to extend Drug Testing Programme to include Arrestees. Programme to use Cozart® RapiScan System
Published: 2005-11-30 12:04:17
Sangamo: Phase 1 Clinical Trial of ZFP Therapeutic in Diabetic Neuropathy
Sangamo BioSciences Completes Enrollment and Treatment in Phase 1 Clinical Trial of ZFP Therapeutic in Diabetic Neuropathy. On Track to Initiate Phase 2 Clinical Trial in 2006
Published: 2005-11-30 11:44:25
News Archive
2004 News Archive
